Supernus Pharmaceuticals Ownership 2024 | Who Owns Supernus Pharmaceuticals Now?
Institutional Ownership
106.11%
Insider Ownership
5.01%
Retail Ownership
-11.12%
Institutional Holders
242.00
Supernus Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 18.90% | 0.01% | 10,392,636 | 30,280 | 0.29% | 278,003,014 | Jun 30, 2024 |
| VANGUARD GROUP INC | 11.16% | 0.00% | 6,137,541 | -69,273 | -1.12% | 164,179,222 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 9.59% | 1.77% | 5,272,000 | 1,700,000 | 47.59% | 141,026,000 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 5.21% | 0.02% | 2,866,887 | 309,966 | 12.12% | 76,689,860 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 4.87% | 0.08% | 2,679,796 | 10,800 | 0.40% | 71,685,000 | Jun 30, 2024 |
| STATE STREET CORP | 3.94% | 0.00% | 2,163,841 | 125,195 | 6.14% | 57,882,747,000 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 3.53% | 0.31% | 1,940,510 | - | - | 51,908,643 | Jun 30, 2024 |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 3.45% | 0.71% | 1,898,499 | -3,277 | -0.17% | 50,784,848 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 3.06% | 0.08% | 1,685,122 | 351,900 | 26.39% | 45,077,014 | Jun 30, 2024 |
| LOOMIS SAYLES & CO L P | 2.83% | 0.06% | 1,556,161 | -41,256 | -2.58% | 41,627,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.56% | 0.00% | 1,407,613 | 100,663 | 7.70% | 37,660,597 | Jun 30, 2024 |
| PACER ADVISORS, INC. | 2.46% | 0.08% | 1,349,854 | 1,348,508 | 100186.33% | 36,108,595 | Jun 30, 2024 |
| GW&K INVESTMENT MANAGEMENT, LLC | 2.35% | 0.32% | 1,293,315 | -46,127 | -3.44% | 34,596,000 | Jun 30, 2024 |
| ARISTOTLE CAPITAL BOSTON, LLC | 2.19% | 1.08% | 1,203,166 | 63,320 | 5.56% | 32,184,681 | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 1.34% | 0.02% | 735,038 | 87,200 | 13.46% | 19,662,266 | Jun 30, 2024 |
| ASHFORD CAPITAL MANAGEMENT INC | 1.29% | 2.57% | 711,894 | -51,571 | -6.75% | 19,043,165 | Jun 30, 2024 |
| MORGAN STANLEY | 1.22% | 0.00% | 670,567 | 20,341 | 3.13% | 17,937,667 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.13% | 0.00% | 621,041 | 28,395 | 4.79% | 16,612,847 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 1.09% | 0.00% | 599,519 | -19,694 | -3.18% | 16,037,134,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.07% | 0.00% | 590,333 | 275,439 | 87.47% | 15,791,408 | Jun 30, 2024 |
Supernus Pharmaceuticals's largest institutional shareholder is BLACKROCK INC., holding 18.90% of the company's total share outstanding, currently valued at $278.00M. The top 10 institutional shareholders own together 66.56% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 1.29% | 2.57% | 711,894 | -51,571 | -6.75% | 19,043,165 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 9.59% | 1.77% | 5,272,000 | 1,700,000 | 47.59% | 141,026,000 | Jun 30, 2024 |
| ARISTOTLE CAPITAL BOSTON, LLC | 2.19% | 1.08% | 1,203,166 | 63,320 | 5.56% | 32,184,681 | Jun 30, 2024 |
| S&T BANK/PA | 0.23% | 0.87% | 127,636 | -47,928 | -27.30% | 3,414,000 | Jun 30, 2024 |
| THIRD AVENUE MANAGEMENT LLC | 0.34% | 0.87% | 189,118 | 29,401 | 18.41% | 5,058,907 | Jun 30, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | 0.91% | 0.81% | 502,586 | -14,187 | -2.75% | 13,444,176 | Jun 30, 2024 |
| TRIBUTARY CAPITAL MANAGEMENT, LLC | 0.63% | 0.77% | 345,121 | 283 | 0.08% | 9,231,987 | Jun 30, 2024 |
| BRIDGE CITY CAPITAL, LLC | 0.15% | 0.74% | 82,285 | 1,625 | 2.01% | 2,201,124 | Jun 30, 2024 |
| BRUCE & CO., INC. | 0.15% | 0.72% | 82,105 | - | - | 2,196,309 | Jun 30, 2024 |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 3.45% | 0.71% | 1,898,499 | -3,277 | -0.17% | 50,784,848 | Jun 30, 2024 |
| VIRTUS INVESTMENT ADVISERS, INC. | 0.05% | 0.66% | 29,148 | - | - | 779,709 | Jun 30, 2024 |
| RETIREMENT PLANNING CO OF NEW ENGLAND, INC. | 0.04% | 0.34% | 23,570 | -1,934 | -7.58% | 630,498 | Jun 30, 2024 |
| MITSUBISHI UFJ ASSET MANAGEMENT (UK) LTD. | 0.04% | 0.33% | 24,000 | - | - | 642,000 | Jun 30, 2024 |
| GW&K INVESTMENT MANAGEMENT, LLC | 2.35% | 0.32% | 1,293,315 | -46,127 | -3.44% | 34,596,000 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 3.53% | 0.31% | 1,940,510 | - | - | 51,908,643 | Jun 30, 2024 |
| MYSTIC ASSET MANAGEMENT, INC. | 0.05% | 0.30% | 27,940 | -1,300 | -4.45% | 747,395 | Jun 30, 2024 |
| SCOUT INVESTMENTS, INC. | 0.44% | 0.17% | 242,329 | -23,196 | -8.74% | 6,482,300 | Jun 30, 2024 |
| PEREGRINE CAPITAL MANAGEMENT LLC | 0.37% | 0.16% | 202,294 | -699 | -0.34% | 5,411,365 | Jun 30, 2024 |
| EDGESTREAM PARTNERS, L.P. | 0.14% | 0.10% | 75,843 | 75,843 | 100.00% | 2,028,800 | Jun 30, 2024 |
| CAMPBELL NEWMAN ASSET MANAGEMENT INC | 0.08% | 0.09% | 43,626 | 91 | 0.21% | 1,166,996 | Jun 30, 2024 |
The largest Supernus Pharmaceuticals shareholder by % of total assets is ASHFORD CAPITAL MANAGEMENT INC. The company owns 711.89K shares of Supernus Pharmaceuticals (SUPN), representing 2.57% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 9.59% | 1.77% | 5,272,000 | 1,700,000 | 47.59% | 141,026,000 | Jun 30, 2024 |
| PACER ADVISORS, INC. | 2.46% | 0.08% | 1,349,854 | 1,348,508 | 100186.33% | 36,108,595 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.91% | 0.01% | 501,658 | 394,728 | 369.15% | 13,419,352 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 3.06% | 0.08% | 1,685,122 | 351,900 | 26.39% | 45,077,014 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 5.21% | 0.02% | 2,866,887 | 309,966 | 12.12% | 76,689,860 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.07% | 0.00% | 590,333 | 275,439 | 87.47% | 15,791,408 | Jun 30, 2024 |
| NORGES BANK | 0.38% | 0.00% | 208,835 | 208,835 | 100.00% | 5,586,336 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.31% | 0.02% | 172,266 | 172,266 | 100.00% | 4,608,116 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.53% | 0.01% | 290,797 | 160,431 | 123.06% | 7,778,820 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.29% | 0.01% | 160,172 | 150,569 | 1567.94% | 4,284,602 | Jun 30, 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0.92% | 0.01% | 508,097 | 150,416 | 42.05% | 13,591,595 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 0.26% | 0.02% | 141,889 | 141,889 | 100.00% | 3,795,354 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.29% | 0.00% | 161,332 | 128,743 | 395.05% | 4,315,631 | Jun 30, 2024 |
| STATE STREET CORP | 3.94% | 0.00% | 2,163,841 | 125,195 | 6.14% | 57,882,747,000 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.21% | 0.00% | 116,322 | 109,088 | 1507.99% | 3,287,260 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.56% | 0.00% | 1,407,613 | 100,663 | 7.70% | 37,660,597 | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 1.34% | 0.02% | 735,038 | 87,200 | 13.46% | 19,662,266 | Jun 30, 2024 |
| EDGESTREAM PARTNERS, L.P. | 0.14% | 0.10% | 75,843 | 75,843 | 100.00% | 2,028,800 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.13% | 0.00% | 73,519 | 73,519 | 100.00% | 1,966,633 | Jun 30, 2024 |
| ARISTOTLE CAPITAL BOSTON, LLC | 2.19% | 1.08% | 1,203,166 | 63,320 | 5.56% | 32,184,681 | Jun 30, 2024 |
As of Jun 30 2024, Supernus Pharmaceuticals's largest institutional buyer is ARMISTICE CAPITAL, LLC. The company purchased 1.70M stocks of SUPN, valued at $141.03M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WOODLINE PARTNERS LP | - | - | - | -1,291,291 | -100.00% | - | Jun 30, 2024 |
| CONGRESS ASSET MANAGEMENT CO /MA | 0.02% | 0.00% | 9,081 | -1,023,060 | -99.12% | 242,907 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.99% | 0.02% | 545,899 | -444,137 | -44.86% | 14,602,798 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.09% | 0.00% | 47,523 | -395,234 | -89.27% | 1,272,000 | Jun 30, 2024 |
| CONGRESS WEALTH MANAGEMENT LLC / DE / | - | - | - | -177,801 | -100.00% | - | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.03% | 0.00% | 14,010 | -173,394 | -92.52% | 377,990 | Jun 30, 2024 |
| EPOCH INVESTMENT PARTNERS, INC. | 0.07% | 0.00% | 35,856 | -166,411 | -82.27% | 959,148 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.24% | 0.00% | 133,224 | -93,808 | -41.32% | 3,563,742 | Jun 30, 2024 |
| STATE OF NEW JERSEY COMMON PENSION FUND D | - | - | - | -92,789 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | 11.16% | 0.00% | 6,137,541 | -69,273 | -1.12% | 164,179,222 | Jun 30, 2024 |
| ASHFORD CAPITAL MANAGEMENT INC | 1.29% | 2.57% | 711,894 | -51,571 | -6.75% | 19,043,165 | Jun 30, 2024 |
| ISTHMUS PARTNERS, LLC | - | - | - | -50,110 | -100.00% | - | Jun 30, 2024 |
| PDT PARTNERS, LLC | - | - | - | -49,030 | -100.00% | - | Jun 30, 2024 |
| S&T BANK/PA | 0.23% | 0.87% | 127,636 | -47,928 | -27.30% | 3,414,000 | Jun 30, 2024 |
| GW&K INVESTMENT MANAGEMENT, LLC | 2.35% | 0.32% | 1,293,315 | -46,127 | -3.44% | 34,596,000 | Jun 30, 2024 |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | 0.51% | 0.08% | 278,436 | -42,484 | -13.24% | 7,448,163 | Jun 30, 2024 |
| TOWNSQUARE CAPITAL LLC | - | - | - | -42,449 | -100.00% | - | Jun 30, 2024 |
| LOOMIS SAYLES & CO L P | 2.83% | 0.06% | 1,556,161 | -41,256 | -2.58% | 41,627,000 | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0.03% | 0.00% | 14,023 | -35,137 | -71.47% | 375,115 | Jun 30, 2024 |
| DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 0.26% | 0.00% | 142,386 | -31,232 | -17.99% | 3,808,825 | Jun 30, 2024 |
As of Jun 30 2024, Supernus Pharmaceuticals's biggest institutional seller is WOODLINE PARTNERS LP. The company sold -1.29M shares of SUPN, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORGES BANK | 0.38% | 0.00% | 208,835 | 208,835 | 100.00% | 5,586,336 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 0.26% | 0.02% | 141,889 | 141,889 | 100.00% | 3,795,354 | Jun 30, 2024 |
| EDGESTREAM PARTNERS, L.P. | 0.14% | 0.10% | 75,843 | 75,843 | 100.00% | 2,028,800 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.13% | 0.00% | 73,519 | 73,519 | 100.00% | 1,966,633 | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 0.07% | 0.00% | 40,000 | 40,000 | 100.00% | 1,070,000 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.06% | 0.02% | 33,770 | 33,770 | 100.00% | 903,348 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 29,330 | 29,330 | 100.00% | 784,578 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 24,405 | 24,405 | 100.00% | 652,834 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.03% | 0.04% | 15,670 | 15,670 | 100.00% | 419,173 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.03% | 0.07% | 15,532 | 15,532 | 100.00% | 415,481 | Jun 30, 2024 |
| STRS OHIO | 0.03% | 0.00% | 13,700 | 13,700 | 100.00% | 366,475,000 | Jun 30, 2024 |
| JAMES INVESTMENT RESEARCH INC | 0.02% | 0.04% | 12,622 | 12,622 | 100.00% | 337,639 | Jun 30, 2024 |
| INTECH INVESTMENT MANAGEMENT LLC | 0.02% | 0.00% | 11,323 | 11,323 | 100.00% | 302,890 | Jun 30, 2024 |
| ATOM INVESTORS LP | 0.02% | 0.02% | 9,106 | 9,106 | 100.00% | 243,586 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.01% | 0.00% | 7,613 | 7,613 | 100.00% | 203,648 | Jun 30, 2024 |
| HEADLANDS TECHNOLOGIES LLC | 0.01% | 0.02% | 6,507 | 6,507 | 100.00% | 174,062 | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | 0.00% | 0.04% | 2,700 | 2,700 | 100.00% | 72,225 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.02% | 1,891 | 1,891 | 100.00% | 50,585 | Jun 30, 2024 |
| MEEDER ASSET MANAGEMENT INC | 0.00% | 0.00% | 1,774 | 1,774 | 100.00% | 47,455 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 201 | 201 | 100.00% | 5,400 | Jun 30, 2024 |
| CAMELOT PORTFOLIOS, LLC | 0.00% | 0.00% | 200 | 200 | 100.00% | 5,350 | Jun 30, 2024 |
| TYLER-STONE WEALTH MANAGEMENT | 0.00% | 0.00% | 118 | 118 | 100.00% | 3,157 | Jun 30, 2024 |
| STEPHENS CONSULTING, LLC | 0.00% | 0.00% | 69 | 69 | 100.00% | 1,846 | Jun 30, 2024 |
| LARSON FINANCIAL GROUP LLC | - | - | 5 | 5 | 100.00% | 134 | Jun 30, 2024 |
Supernus Pharmaceuticals's largest new institutional shareholder by number of shares is NORGES BANK, purchased 208.84K shares, valued at $5.59M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WOODLINE PARTNERS LP | - | - | - | -1,291,291 | -100.00% | - | Jun 30, 2024 |
| CONGRESS WEALTH MANAGEMENT LLC / DE / | - | - | - | -177,801 | -100.00% | - | Jun 30, 2024 |
| STATE OF NEW JERSEY COMMON PENSION FUND D | - | - | - | -92,789 | -100.00% | - | Jun 30, 2024 |
| ISTHMUS PARTNERS, LLC | - | - | - | -50,110 | -100.00% | - | Jun 30, 2024 |
| PDT PARTNERS, LLC | - | - | - | -49,030 | -100.00% | - | Jun 30, 2024 |
| TOWNSQUARE CAPITAL LLC | - | - | - | -42,449 | -100.00% | - | Jun 30, 2024 |
| CAPULA MANAGEMENT LTD | - | - | - | -27,693 | -100.00% | - | Jun 30, 2024 |
| J. GOLDMAN & CO LP | - | - | - | -27,000 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -26,758 | -100.00% | - | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | - | - | - | -18,174 | -100.00% | - | Jun 30, 2024 |
| SEAPORT GLOBAL ADVISORS, LLC | - | - | - | -16,069 | -100.00% | - | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | - | - | - | -15,899 | -100.00% | - | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | - | - | - | -14,700 | -100.00% | - | Jun 30, 2024 |
| GUGGENHEIM CAPITAL LLC | - | - | - | -14,100 | -100.00% | - | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -11,494 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -10,979 | -100.00% | - | Jun 30, 2024 |
| ENVESTNET PORTFOLIO SOLUTIONS, INC. | - | - | - | -9,188 | -100.00% | - | Jun 30, 2024 |
| NORDEN GROUP LLC | - | - | - | -8,560 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -6,654 | -100.00% | - | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -6,502 | -100.00% | - | Jun 30, 2024 |
| MML INVESTORS SERVICES, LLC | - | - | - | -6,318 | -100.00% | - | Jun 30, 2024 |
| CERITY PARTNERS LLC | - | - | - | -6,123 | -100.00% | - | Jun 30, 2024 |
| PATHSTONE HOLDINGS, LLC | - | - | - | -6,067 | -100.00% | - | Jun 30, 2024 |
| HANCOCK WHITNEY CORP | - | - | - | -5,885 | -100.00% | - | Jun 30, 2024 |
| POINT72 (DIFC) LTD | - | - | - | -4,201 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -2,615 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -1,274 | -100.00% | - | Jun 30, 2024 |
| FIDELIS CAPITAL PARTNERS, LLC | - | - | - | -959 | -100.00% | - | Jun 30, 2024 |
| CORECAP ADVISORS, LLC | - | - | - | -325 | -100.00% | - | Jun 30, 2024 |
| PARK PLACE CAPITAL CORP | - | - | - | -198 | -100.00% | - | Jun 30, 2024 |
| CREWE ADVISORS LLC | - | - | - | -85 | -100.00% | - | Jun 30, 2024 |
| FIRST FINANCIAL CORP /IN/ | - | - | - | -66 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -46 | -100.00% | - | Jun 30, 2024 |
| VALLEY NATIONAL ADVISERS INC | - | - | - | -40 | -100.00% | - | Jun 30, 2024 |
| CAPE INVESTMENT ADVISORY, INC. | - | - | - | -29 | -100.00% | - | Jun 30, 2024 |
Supernus Pharmaceuticals's largest sold out institutional shareholder by shares sold is WOODLINE PARTNERS LP, sold -1.29M shares, valued at -, as of undefined.
Supernus Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| SCHRODER GLOBAL SERIES TRUST | 2.67% | 5,439 | - | - | Jan 31, 2021 |
| GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC | 1.58% | 1,250,000 | - | - | Dec 29, 2023 |
| TETON WESTWOOD FUNDS | 1.09% | 708,000 | - | - | Dec 29, 2023 |
| BANCROFT FUND LTD | 0.93% | 1,288,000 | - | - | Dec 29, 2023 |
| ELLSWORTH GROWTH & INCOME FUND LTD | 0.89% | 1,254,000 | - | - | Dec 29, 2023 |
| ROYCE CAPITAL FUND | 0.28% | 106,900 | - | - | Mar 31, 2024 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.16% | 11,582 | - | - | Sep 30, 2022 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.13% | 24,221 | 19,691 | 434.68% | Mar 28, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.09% | 303,400 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.08% | 1,007,005 | 133,286 | 15.26% | Jan 31, 2024 |
| Monteagle Funds | 0.08% | 3,300 | - | - | Feb 29, 2024 |
| VANGUARD ADMIRAL FUNDS | 0.08% | 333,920 | 48,355 | 16.93% | Feb 29, 2024 |
| SIT MUTUAL FUNDS INC | 0.07% | 27,725 | 21,000 | 312.27% | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.07% | 36,654 | - | - | Mar 31, 2024 |
| M FUND INC | 0.07% | 30,965 | - | - | Mar 31, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.06% | 22,687 | - | - | Mar 31, 2024 |
| EntrepreneurShares Series Trust | 0.06% | 16,069 | 8,127 | 102.33% | Dec 31, 2023 |
| BNY MELLON INDEX FUNDS, INC. | 0.05% | 55,851 | -7,446 | -11.76% | Jan 31, 2024 |
| Capitol Series Trust | 0.05% | 489,348 | - | - | Jan 31, 2024 |
| SYNTAX ETF TRUST | 0.05% | 1,508 | 290 | 23.81% | Mar 31, 2024 |
| BNY MELLON INVESTMENT PORTFOLIOS | 0.05% | 27,317 | -78 | -0.28% | Mar 31, 2024 |
| Tributary Funds, Inc. | 0.04% | 229,335 | -3,689 | -1.58% | Dec 31, 2023 |
| VALUED ADVISERS TRUST | 0.04% | 40,094 | - | - | Jan 31, 2024 |
| BRUCE FUND INC | 0.04% | 82,105 | - | - | Dec 31, 2023 |
| DELAWARE GROUP EQUITY FUNDS V | 0.04% | 2,077,345 | -8,439 | -0.40% | Feb 29, 2024 |
| Humankind Benefit Corp | 0.03% | 644 | 74 | 12.98% | Dec 31, 2023 |
| THIRD AVENUE TRUST | 0.03% | 159,717 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL FUNDS | 0.03% | 20,450 | - | - | Mar 31, 2024 |
| TETON WESTWOOD FUNDS | 0.02% | 15,800 | - | - | Dec 29, 2023 |
| HUSSMAN INVESTMENT TRUST | 0.02% | 75,600 | -18,000 | -19.23% | Dec 31, 2023 |
| SARATOGA ADVANTAGE TRUST | 0.02% | 1,290 | - | - | Feb 29, 2024 |
| ROYCE VALUE TRUST, INC. | 0.02% | 15,522 | - | - | Mar 31, 2024 |
| MUTUAL OF AMERICA INSTITUTIONAL FUNDS INC | 0.02% | 10,185 | 2,695 | 35.98% | Sep 30, 2020 |
| Federated Hermes MDT Series | 0.02% | 44,531 | -10,053 | -18.42% | Jan 31, 2024 |
| PFM Multi-Manager Series Trust | 0.02% | 14,349 | - | - | Dec 31, 2023 |
| Voya PARTNERS INC | 0.02% | 1,323,000 | - | - | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.02% | 22,795 | 6,463 | 39.57% | Feb 29, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.01% | 33,120 | 10,869 | 48.85% | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 86,245 | -3,255 | -3.64% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.01% | 48,909 | -4,313 | -8.10% | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 7,430 | - | - | Mar 31, 2024 |
| FIDELITY CONTRAFUND | 0.01% | 825,096 | - | - | Mar 31, 2024 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.01% | 8,624 | 198 | 2.35% | Sep 30, 2023 |
| AMG Funds IV | 0.01% | 35,110 | - | - | Jan 31, 2024 |
| AMG FUNDS | 0.01% | 329,224 | -10,990 | -3.23% | Mar 28, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 4,666,630 | -811,440 | -14.81% | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.01% | 327,900 | -25,400 | -7.19% | Mar 31, 2024 |
| Vericimetry Funds | 0.01% | 892 | - | - | Mar 31, 2024 |
| RANGER FUNDS INVESTMENT TRUST | 0.01% | 347 | 347 | - | Apr 30, 2020 |
| FORUM FUNDS II | 0.01% | 8,828 | 1,443 | 19.54% | Mar 31, 2024 |
| 360 Funds | 0.01% | 1,627 | 395 | 32.06% | Feb 29, 2024 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.01% | 312,403 | -12,119 | -3.73% | Mar 31, 2024 |
| PROFESSIONALLY MANAGED PORTFOLIOS | 0.01% | 570,000 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,648 | - | - | Mar 31, 2024 |
| EXCHANGE TRADED CONCEPTS TRUST | 0.01% | 43,261 | 2,008 | 4.87% | Feb 29, 2024 |
| MADISON FUNDS | 0.01% | 41,808 | - | - | Jan 31, 2024 |
| JNL VARIABLE FUND LLC | 0.01% | 38,040 | - | - | Mar 31, 2020 |
| Bernstein Fund Inc | 0.01% | 57,920 | - | - | Mar 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS 12 | 0.01% | 19,000 | - | - | Jan 31, 2024 |
| ROYCE FUND | 0.01% | 41,033 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 19,186 | 310 | 1.64% | Feb 29, 2024 |
| FORUM FUNDS | 0.01% | 13,715 | - | - | Jan 31, 2024 |
| PPM Funds | 0.01% | 4,750 | - | - | Mar 31, 2024 |
| TARGET PORTFOLIO TRUST | 0.01% | 112,200 | - | - | Jan 31, 2024 |
| Pear Tree Funds | 0.01% | 42,500 | - | - | Mar 31, 2024 |
| US GLOBAL INVESTORS FUNDS | 0.01% | 29,514 | - | - | Mar 31, 2024 |
| SSGA FUNDS | 0.00% | 1,976 | - | - | Feb 29, 2024 |
| World Funds Trust | 0.00% | 53,285 | - | - | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 361,025 | 5,936 | 1.67% | Jan 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 139,253 | -7,859 | -5.34% | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 39,546 | 6,037 | 18.02% | Mar 28, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 9,280 | -5,549 | -37.42% | Feb 29, 2024 |
| IndexIQ ETF Trust | 0.00% | 8,975 | -632 | -6.58% | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 161,845 | 2,372 | 1.49% | Jan 31, 2024 |
| AMG FUNDS III | 0.00% | 19,731 | - | - | Mar 28, 2024 |
| DELAWARE VIP TRUST | 0.00% | 13,093 | -321 | -2.39% | Mar 28, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.00% | 18,015 | - | - | Mar 31, 2024 |
| ROYCE MICRO-CAP TRUST, INC. | 0.00% | 1,300 | - | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 63,434 | -17,596 | -21.72% | Mar 31, 2024 |
| Lattice Strategies Trust | 0.00% | 3,797 | -2,975 | -43.93% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 518,065 | 12,385 | 2.45% | Feb 29, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 54,100 | - | - | Jan 31, 2024 |
| CARILLON SERIES TRUST | 0.00% | 122,051 | -8,381 | -6.43% | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 385,000 | - | - | Feb 29, 2024 |
| VANGUARD TAX-MANAGED FUNDS | 0.00% | 422,061 | -4,865 | -1.14% | Mar 31, 2024 |
| TIMOTHY PLAN | 0.00% | 9,558 | 1,287 | 15.56% | Mar 31, 2024 |
| FINANCIAL INVESTORS TRUST | 0.00% | 156,314 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 4,884 | - | - | Mar 31, 2024 |
| Legg Mason ETF Investment Trust | 0.00% | 3,568 | 340 | 10.53% | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 1,840,295 | 415,533 | 29.17% | Jan 31, 2024 |
| GLENMEDE FUND INC | 0.00% | 15,065 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 721,553 | 81,918 | 12.81% | Jan 31, 2024 |
| Ivy Variable Insurance Portfolios | 0.00% | 36,110 | -1,896 | -4.99% | Mar 28, 2024 |
| KP Funds | 0.00% | 68,607 | -600 | -0.87% | Sep 30, 2020 |
| SHELTON FUNDS | 0.00% | 2,544 | -401 | -13.62% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 45,246 | -34,116 | -42.99% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 16,886 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 9,506 | - | - | Jan 31, 2024 |
| STEWARD FUNDS, INC. | 0.00% | 3,141 | - | - | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 1,411 | 292 | 26.09% | Dec 31, 2023 |
Supernus Pharmaceuticals's largest mutual fund holder by % of total assets is "SCHRODER GLOBAL SERIES TRUST", owning 5.44K shares, compromising 2.67% of its total assets.
Supernus Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 242 | -4.72% |
| 31 Mar, 24 | 254 | 2.42% |
| 31 Dec, 23 | 248 | 3.33% |
| 30 Sep, 23 | 240 | -5.51% |
| 30 Jun, 23 | 254 | -3.05% |
| 31 Mar, 23 | 262 | - |
| 31 Dec, 22 | 262 | 8.71% |
| 30 Sep, 22 | 241 | 8.07% |
| 30 Jun, 22 | 223 | -3.46% |
| 31 Mar, 22 | 231 | -2.53% |
| 31 Dec, 21 | 237 | 3.04% |
| 30 Sep, 21 | 230 | -1.71% |
| 30 Jun, 21 | 234 | 3.54% |
| 31 Mar, 21 | 226 | -1.74% |
| 31 Dec, 20 | 230 | 7.48% |
| 30 Sep, 20 | 214 | -3.17% |
| 30 Jun, 20 | 221 | 3.76% |
| 31 Mar, 20 | 213 | -12.35% |
| 31 Dec, 19 | 243 | -2.80% |
| 30 Sep, 19 | 250 | -10.71% |
| 30 Jun, 19 | 280 | -6.04% |
| 31 Mar, 19 | 298 | 4.93% |
| 31 Dec, 18 | 284 | -4.05% |
| 30 Sep, 18 | 296 | -9.48% |
| 30 Jun, 18 | 327 | 2.83% |
| 31 Mar, 18 | 318 | 5.65% |
| 31 Dec, 17 | 301 | 4.88% |
| 30 Sep, 17 | 287 | 3.61% |
| 30 Jun, 17 | 277 | 6.13% |
| 31 Mar, 17 | 261 | 8.30% |
| 31 Dec, 16 | 241 | 5.70% |
| 30 Sep, 16 | 228 | 3.64% |
| 30 Jun, 16 | 220 | 0.46% |
| 31 Mar, 16 | 219 | 4.29% |
| 31 Dec, 15 | 210 | 10.53% |
| 30 Sep, 15 | 190 | 12.43% |
| 30 Jun, 15 | 169 | 33.07% |
| 31 Mar, 15 | 127 | 12.39% |
| 31 Dec, 14 | 113 | 15.31% |
| 30 Sep, 14 | 98 | 2.08% |
| 30 Jun, 14 | 96 | 3.23% |
| 31 Mar, 14 | 93 | 38.81% |
| 31 Dec, 13 | 67 | 1.52% |
| 30 Sep, 13 | 66 | 15.79% |
| 30 Jun, 13 | 57 | 307.14% |
| 31 Mar, 13 | 14 | -6.67% |
| 31 Dec, 12 | 15 | 36.36% |
| 30 Sep, 12 | 11 | -8.33% |
| 30 Jun, 12 | 12 | - |
As of 30 Jun 24, 242 institutions are holding Supernus Pharmaceuticals's shares, representing a decrease of -4.72% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 58,340,579 | 3.32% |
| 31 Mar, 24 | 56,466,578 | -1.13% |
| 31 Dec, 23 | 57,110,886 | 0.73% |
| 30 Sep, 23 | 56,699,578 | -1.25% |
| 30 Jun, 23 | 57,418,359 | 3.11% |
| 31 Mar, 23 | 55,685,513 | -0.16% |
| 31 Dec, 22 | 55,777,463 | 0.37% |
| 30 Sep, 22 | 55,572,733 | 1.55% |
| 30 Jun, 22 | 54,722,499 | 1.76% |
| 31 Mar, 22 | 53,775,375 | -2.59% |
| 31 Dec, 21 | 55,206,899 | 1.49% |
| 30 Sep, 21 | 54,398,068 | 0.37% |
| 30 Jun, 21 | 54,195,313 | 1.68% |
| 31 Mar, 21 | 53,298,723 | 0.73% |
| 31 Dec, 20 | 52,914,225 | 2.97% |
| 30 Sep, 20 | 51,389,392 | 1.70% |
| 30 Jun, 20 | 50,530,831 | 2.19% |
| 31 Mar, 20 | 49,449,241 | -3.62% |
| 31 Dec, 19 | 51,308,741 | 1.32% |
| 30 Sep, 19 | 50,640,003 | -4.25% |
| 30 Jun, 19 | 52,886,471 | -0.49% |
| 31 Mar, 19 | 53,149,349 | 2.40% |
| 31 Dec, 18 | 51,901,445 | 0.32% |
| 30 Sep, 18 | 51,738,163 | -3.52% |
| 30 Jun, 18 | 53,626,050 | 4.61% |
| 31 Mar, 18 | 51,263,681 | 3.22% |
| 31 Dec, 17 | 49,665,176 | -2.24% |
| 30 Sep, 17 | 50,805,301 | 5.03% |
| 30 Jun, 17 | 48,371,312 | 4.91% |
| 31 Mar, 17 | 46,106,854 | 1.70% |
| 31 Dec, 16 | 45,334,024 | -1.58% |
| 30 Sep, 16 | 46,059,799 | -1.71% |
| 30 Jun, 16 | 46,858,896 | 4.28% |
| 31 Mar, 16 | 44,937,202 | 0.61% |
| 31 Dec, 15 | 44,663,547 | -4.89% |
| 30 Sep, 15 | 46,961,588 | 10.37% |
| 30 Jun, 15 | 42,547,543 | 5.14% |
| 31 Mar, 15 | 40,468,057 | 9.16% |
| 31 Dec, 14 | 37,071,138 | 3.99% |
| 30 Sep, 14 | 35,649,849 | -3.97% |
| 30 Jun, 14 | 37,124,883 | 11.12% |
| 31 Mar, 14 | 33,410,025 | 7.77% |
| 31 Dec, 13 | 31,002,440 | 21.76% |
| 30 Sep, 13 | 25,462,294 | -3.66% |
| 30 Jun, 13 | 26,429,232 | 158.88% |
| 31 Mar, 13 | 10,209,117 | 12.53% |
| 31 Dec, 12 | 9,072,679 | 32.38% |
| 30 Sep, 12 | 6,853,697 | -34.03% |
| 30 Jun, 12 | 10,389,099 | - |
Supernus Pharmaceuticals (SUPN) has 58.34M shares outstanding as of 30 Jun 24, up 3.32% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 106.11% | 1.00% |
| 31 Mar, 24 | 103.04% | 0.94% |
| 31 Dec, 23 | 104.51% | 0.97% |
| 30 Sep, 23 | 103.83% | 0.94% |
| 30 Jun, 23 | 105.35% | 1.00% |
| 31 Mar, 23 | 102.40% | 0.95% |
| 31 Dec, 22 | 103.94% | 0.97% |
| 30 Sep, 22 | 103.31% | 0.98% |
| 30 Jun, 22 | 102.43% | 1.25% |
| 31 Mar, 22 | 90.60% | 0.84% |
| 31 Dec, 21 | 103.70% | 0.99% |
| 30 Sep, 21 | 102.28% | 0.98% |
| 30 Jun, 21 | 102.25% | 1.01% |
| 31 Mar, 21 | 100.70% | 1.00% |
| 31 Dec, 20 | 100.57% | 1.06% |
| 30 Sep, 20 | 97.59% | 1.06% |
| 30 Jun, 20 | 96.14% | 1.09% |
| 31 Mar, 20 | 94.13% | 0.98% |
| 31 Dec, 19 | 97.78% | 1.05% |
| 30 Sep, 19 | 96.54% | 0.95% |
| 30 Jun, 19 | 100.96% | 0.98% |
| 31 Mar, 19 | 101.55% | 1.03% |
| 31 Dec, 18 | 99.31% | 1.01% |
| 30 Sep, 18 | 99.06% | 0.93% |
| 30 Jun, 18 | 103.29% | 1.04% |
| 31 Mar, 18 | 99.47% | 1.06% |
| 31 Dec, 17 | 96.87% | 0.98% |
| 30 Sep, 17 | 99.53% | 1.09% |
| 30 Jun, 17 | 95.73% | 1.13% |
| 31 Mar, 17 | 91.92% | 1.10% |
| 31 Dec, 16 | 91.21% | 1.05% |
| 30 Sep, 16 | 93.02% | 1.03% |
| 30 Jun, 16 | 94.80% | 1.14% |
| 31 Mar, 16 | 91.26% | 1.03% |
| 31 Dec, 15 | 94.06% | 1.00% |
| 30 Sep, 15 | 96.80% | 1.23% |
| 30 Jun, 15 | 88.80% | 1.08% |
| 31 Mar, 15 | 90.81% | 1.18% |
| 31 Dec, 14 | 87.72% | 1.27% |
| 30 Sep, 14 | 83.10% | 1.07% |
| 30 Jun, 14 | 88.27% | 1.32% |
| 31 Mar, 14 | 81.68% | 1.01% |
| 31 Dec, 13 | 89.91% | 1.32% |
| 30 Sep, 13 | 82.42% | 1.11% |
| 30 Jun, 13 | 85.98% | 7.86% |
| 31 Mar, 13 | 33.07% | 1.22% |
| 31 Dec, 12 | 52.03% | 6.63% |
| 30 Sep, 12 | 28.02% | 0.73% |
| 30 Jun, 12 | 61.77% | - |
As of 30 Jun 24, Supernus Pharmaceuticals is held by 106.11% institutional shareholders, representing a 1.00% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 115 | 8.49% |
| 31 Mar, 24 | 106 | -10.17% |
| 31 Dec, 23 | 118 | 9.26% |
| 30 Sep, 23 | 108 | -10.74% |
| 30 Jun, 23 | 121 | 3.42% |
| 31 Mar, 23 | 117 | -11.36% |
| 31 Dec, 22 | 132 | 3.94% |
| 30 Sep, 22 | 127 | 16.51% |
| 30 Jun, 22 | 109 | 4.81% |
| 31 Mar, 22 | 104 | -21.21% |
| 31 Dec, 21 | 132 | 20.00% |
| 30 Sep, 21 | 110 | 6.80% |
| 30 Jun, 21 | 103 | -4.63% |
| 31 Mar, 21 | 108 | - |
| 31 Dec, 20 | 108 | 4.85% |
| 30 Sep, 20 | 103 | -13.45% |
| 30 Jun, 20 | 119 | 32.22% |
| 31 Mar, 20 | 90 | -21.05% |
| 31 Dec, 19 | 114 | 5.56% |
| 30 Sep, 19 | 108 | -15.63% |
| 30 Jun, 19 | 128 | -21.47% |
| 31 Mar, 19 | 163 | 18.12% |
| 31 Dec, 18 | 138 | 7.81% |
| 30 Sep, 18 | 128 | -19.50% |
| 30 Jun, 18 | 159 | -1.85% |
| 31 Mar, 18 | 162 | 5.88% |
| 31 Dec, 17 | 153 | 17.69% |
| 30 Sep, 17 | 130 | -9.72% |
| 30 Jun, 17 | 144 | 6.67% |
| 31 Mar, 17 | 135 | 28.57% |
| 31 Dec, 16 | 105 | -6.25% |
| 30 Sep, 16 | 112 | -5.88% |
| 30 Jun, 16 | 119 | -2.46% |
| 31 Mar, 16 | 122 | -7.58% |
| 31 Dec, 15 | 132 | 18.92% |
| 30 Sep, 15 | 111 | -13.95% |
| 30 Jun, 15 | 129 | 74.32% |
| 31 Mar, 15 | 74 | 15.63% |
| 31 Dec, 14 | 64 | 25.49% |
| 30 Sep, 14 | 51 | -10.53% |
| 30 Jun, 14 | 57 | 14.00% |
| 31 Mar, 14 | 50 | 42.86% |
| 31 Dec, 13 | 35 | -2.78% |
| 30 Sep, 13 | 36 | -23.40% |
| 30 Jun, 13 | 47 | 261.54% |
| 31 Mar, 13 | 13 | 30.00% |
| 31 Dec, 12 | 10 | 11.11% |
| 30 Sep, 12 | 9 | -25.00% |
| 30 Jun, 12 | 12 | - |
115 institutional shareholders have increased their position in SUPN stock as of 30 Jun 24 compared to 106 in the previous quarter (a 8.49% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 80 | -15.79% |
| 31 Mar, 24 | 95 | 7.95% |
| 31 Dec, 23 | 88 | -5.38% |
| 30 Sep, 23 | 93 | 4.49% |
| 30 Jun, 23 | 89 | -8.25% |
| 31 Mar, 23 | 97 | 10.23% |
| 31 Dec, 22 | 88 | 17.33% |
| 30 Sep, 22 | 75 | -8.54% |
| 30 Jun, 22 | 82 | -16.33% |
| 31 Mar, 22 | 98 | 50.77% |
| 31 Dec, 21 | 65 | -14.47% |
| 30 Sep, 21 | 76 | -12.64% |
| 30 Jun, 21 | 87 | 16.00% |
| 31 Mar, 21 | 75 | -10.71% |
| 31 Dec, 20 | 84 | 20.00% |
| 30 Sep, 20 | 70 | 1.45% |
| 30 Jun, 20 | 69 | -21.59% |
| 31 Mar, 20 | 88 | -1.12% |
| 31 Dec, 19 | 89 | -3.26% |
| 30 Sep, 19 | 92 | -5.15% |
| 30 Jun, 19 | 97 | 27.63% |
| 31 Mar, 19 | 76 | -18.28% |
| 31 Dec, 18 | 93 | -16.22% |
| 30 Sep, 18 | 111 | -7.50% |
| 30 Jun, 18 | 120 | 3.45% |
| 31 Mar, 18 | 116 | 9.43% |
| 31 Dec, 17 | 106 | -4.50% |
| 30 Sep, 17 | 111 | 14.43% |
| 30 Jun, 17 | 97 | 8.99% |
| 31 Mar, 17 | 89 | -12.75% |
| 31 Dec, 16 | 102 | 8.51% |
| 30 Sep, 16 | 94 | 32.39% |
| 30 Jun, 16 | 71 | -11.25% |
| 31 Mar, 16 | 80 | 42.86% |
| 31 Dec, 15 | 56 | -5.08% |
| 30 Sep, 15 | 59 | 103.45% |
| 30 Jun, 15 | 29 | -3.33% |
| 31 Mar, 15 | 30 | 11.11% |
| 31 Dec, 14 | 27 | - |
| 30 Sep, 14 | 27 | 22.73% |
| 30 Jun, 14 | 22 | 10.00% |
| 31 Mar, 14 | 20 | 25.00% |
| 31 Dec, 13 | 16 | -11.11% |
| 30 Sep, 13 | 18 | 350.00% |
| 30 Jun, 13 | 4 | 300.00% |
| 31 Mar, 13 | 1 | -75.00% |
| 31 Dec, 12 | 4 | 300.00% |
| 30 Sep, 12 | 1 | - |
| 30 Jun, 12 | - | - |
80 institutional shareholders have reduced their position in SUPN stock as of 30 Jun 24 compared to 95 in the previous quarter (a -15.79% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 242 | -4.72% | 58,340,579 | 3.32% | 106.11% | 1.00% | 115 | 8.49% | 80 | -15.79% |
| 31 Mar, 24 | 254 | 2.42% | 56,466,578 | -1.13% | 103.04% | 0.94% | 106 | -10.17% | 95 | 7.95% |
| 31 Dec, 23 | 248 | 3.33% | 57,110,886 | 0.73% | 104.51% | 0.97% | 118 | 9.26% | 88 | -5.38% |
| 30 Sep, 23 | 240 | -5.51% | 56,699,578 | -1.25% | 103.83% | 0.94% | 108 | -10.74% | 93 | 4.49% |
| 30 Jun, 23 | 254 | -3.05% | 57,418,359 | 3.11% | 105.35% | 1.00% | 121 | 3.42% | 89 | -8.25% |
| 31 Mar, 23 | 262 | - | 55,685,513 | -0.16% | 102.40% | 0.95% | 117 | -11.36% | 97 | 10.23% |
| 31 Dec, 22 | 262 | 8.71% | 55,777,463 | 0.37% | 103.94% | 0.97% | 132 | 3.94% | 88 | 17.33% |
| 30 Sep, 22 | 241 | 8.07% | 55,572,733 | 1.55% | 103.31% | 0.98% | 127 | 16.51% | 75 | -8.54% |
| 30 Jun, 22 | 223 | -3.46% | 54,722,499 | 1.76% | 102.43% | 1.25% | 109 | 4.81% | 82 | -16.33% |
| 31 Mar, 22 | 231 | -2.53% | 53,775,375 | -2.59% | 90.60% | 0.84% | 104 | -21.21% | 98 | 50.77% |
| 31 Dec, 21 | 237 | 3.04% | 55,206,899 | 1.49% | 103.70% | 0.99% | 132 | 20.00% | 65 | -14.47% |
| 30 Sep, 21 | 230 | -1.71% | 54,398,068 | 0.37% | 102.28% | 0.98% | 110 | 6.80% | 76 | -12.64% |
| 30 Jun, 21 | 234 | 3.54% | 54,195,313 | 1.68% | 102.25% | 1.01% | 103 | -4.63% | 87 | 16.00% |
| 31 Mar, 21 | 226 | -1.74% | 53,298,723 | 0.73% | 100.70% | 1.00% | 108 | - | 75 | -10.71% |
| 31 Dec, 20 | 230 | 7.48% | 52,914,225 | 2.97% | 100.57% | 1.06% | 108 | 4.85% | 84 | 20.00% |
| 30 Sep, 20 | 214 | -3.17% | 51,389,392 | 1.70% | 97.59% | 1.06% | 103 | -13.45% | 70 | 1.45% |
| 30 Jun, 20 | 221 | 3.76% | 50,530,831 | 2.19% | 96.14% | 1.09% | 119 | 32.22% | 69 | -21.59% |
| 31 Mar, 20 | 213 | -12.35% | 49,449,241 | -3.62% | 94.13% | 0.98% | 90 | -21.05% | 88 | -1.12% |
| 31 Dec, 19 | 243 | -2.80% | 51,308,741 | 1.32% | 97.78% | 1.05% | 114 | 5.56% | 89 | -3.26% |
| 30 Sep, 19 | 250 | -10.71% | 50,640,003 | -4.25% | 96.54% | 0.95% | 108 | -15.63% | 92 | -5.15% |
| 30 Jun, 19 | 280 | -6.04% | 52,886,471 | -0.49% | 100.96% | 0.98% | 128 | -21.47% | 97 | 27.63% |
| 31 Mar, 19 | 298 | 4.93% | 53,149,349 | 2.40% | 101.55% | 1.03% | 163 | 18.12% | 76 | -18.28% |
| 31 Dec, 18 | 284 | -4.05% | 51,901,445 | 0.32% | 99.31% | 1.01% | 138 | 7.81% | 93 | -16.22% |
| 30 Sep, 18 | 296 | -9.48% | 51,738,163 | -3.52% | 99.06% | 0.93% | 128 | -19.50% | 111 | -7.50% |
| 30 Jun, 18 | 327 | 2.83% | 53,626,050 | 4.61% | 103.29% | 1.04% | 159 | -1.85% | 120 | 3.45% |
| 31 Mar, 18 | 318 | 5.65% | 51,263,681 | 3.22% | 99.47% | 1.06% | 162 | 5.88% | 116 | 9.43% |
| 31 Dec, 17 | 301 | 4.88% | 49,665,176 | -2.24% | 96.87% | 0.98% | 153 | 17.69% | 106 | -4.50% |
| 30 Sep, 17 | 287 | 3.61% | 50,805,301 | 5.03% | 99.53% | 1.09% | 130 | -9.72% | 111 | 14.43% |
| 30 Jun, 17 | 277 | 6.13% | 48,371,312 | 4.91% | 95.73% | 1.13% | 144 | 6.67% | 97 | 8.99% |
| 31 Mar, 17 | 261 | 8.30% | 46,106,854 | 1.70% | 91.92% | 1.10% | 135 | 28.57% | 89 | -12.75% |
| 31 Dec, 16 | 241 | 5.70% | 45,334,024 | -1.58% | 91.21% | 1.05% | 105 | -6.25% | 102 | 8.51% |
| 30 Sep, 16 | 228 | 3.64% | 46,059,799 | -1.71% | 93.02% | 1.03% | 112 | -5.88% | 94 | 32.39% |
| 30 Jun, 16 | 220 | 0.46% | 46,858,896 | 4.28% | 94.80% | 1.14% | 119 | -2.46% | 71 | -11.25% |
| 31 Mar, 16 | 219 | 4.29% | 44,937,202 | 0.61% | 91.26% | 1.03% | 122 | -7.58% | 80 | 42.86% |
| 31 Dec, 15 | 210 | 10.53% | 44,663,547 | -4.89% | 94.06% | 1.00% | 132 | 18.92% | 56 | -5.08% |
| 30 Sep, 15 | 190 | 12.43% | 46,961,588 | 10.37% | 96.80% | 1.23% | 111 | -13.95% | 59 | 103.45% |
| 30 Jun, 15 | 169 | 33.07% | 42,547,543 | 5.14% | 88.80% | 1.08% | 129 | 74.32% | 29 | -3.33% |
| 31 Mar, 15 | 127 | 12.39% | 40,468,057 | 9.16% | 90.81% | 1.18% | 74 | 15.63% | 30 | 11.11% |
| 31 Dec, 14 | 113 | 15.31% | 37,071,138 | 3.99% | 87.72% | 1.27% | 64 | 25.49% | 27 | - |
| 30 Sep, 14 | 98 | 2.08% | 35,649,849 | -3.97% | 83.10% | 1.07% | 51 | -10.53% | 27 | 22.73% |
| 30 Jun, 14 | 96 | 3.23% | 37,124,883 | 11.12% | 88.27% | 1.32% | 57 | 14.00% | 22 | 10.00% |
| 31 Mar, 14 | 93 | 38.81% | 33,410,025 | 7.77% | 81.68% | 1.01% | 50 | 42.86% | 20 | 25.00% |
| 31 Dec, 13 | 67 | 1.52% | 31,002,440 | 21.76% | 89.91% | 1.32% | 35 | -2.78% | 16 | -11.11% |
| 30 Sep, 13 | 66 | 15.79% | 25,462,294 | -3.66% | 82.42% | 1.11% | 36 | -23.40% | 18 | 350.00% |
| 30 Jun, 13 | 57 | 307.14% | 26,429,232 | 158.88% | 85.98% | 7.86% | 47 | 261.54% | 4 | 300.00% |
| 31 Mar, 13 | 14 | -6.67% | 10,209,117 | 12.53% | 33.07% | 1.22% | 13 | 30.00% | 1 | -75.00% |
| 31 Dec, 12 | 15 | 36.36% | 9,072,679 | 32.38% | 52.03% | 6.63% | 10 | 11.11% | 4 | 300.00% |
| 30 Sep, 12 | 11 | -8.33% | 6,853,697 | -34.03% | 28.02% | 0.73% | 9 | -25.00% | 1 | - |
| 30 Jun, 12 | 12 | - | 10,389,099 | - | 61.77% | - | 12 | - | - | - |
Supernus Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Supernus Pharmaceuticals's stock was made by Bhatt Padmanabh P. on Mar 25 2024, selling 14,491 shares at $25.30 per share (valued at $366.62K).
Supernus Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 48 | 43 | 111.63% |
| Q4 2023 | 9 | 13 | 69.23% |
| Q3 2023 | 6 | 7 | 85.71% |
| Q2 2023 | 7 | 5 | 140.00% |
| Q1 2023 | 55 | 41 | 134.15% |
| Q4 2022 | 12 | 21 | 57.14% |
| Q3 2022 | 7 | 24 | 29.17% |
| Q1 2022 | 40 | 7 | 571.43% |
| Q3 2021 | 4 | 1 | 400.00% |
| Q2 2021 | 1 | 4 | 25.00% |
| Q1 2021 | 17 | 2 | 850.00% |
| Q4 2020 | 7 | 12 | 58.33% |
| Q3 2020 | 3 | 4 | 75.00% |
| Q2 2020 | 2 | 4 | 50.00% |
| Q1 2020 | 16 | 17 | 94.12% |
| Q4 2019 | 1 | 3 | 33.33% |
| Q3 2019 | 1 | 1 | 100.00% |
| Q2 2019 | 2 | 2 | 100.00% |
| Q1 2019 | 13 | 6 | 216.67% |
| Q4 2018 | - | - | - |
48 total buy trades, and 43 total sell trades (buy/sell ratio of 1.12%) were made by Supernus Pharmaceuticals's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | - | 7 | - |
| Q4 2023 | - | 4 | - |
| Q3 2023 | - | 2 | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | 9 | - |
| Q4 2022 | - | 10 | - |
| Q3 2022 | - | 8 | - |
| Q1 2022 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | 2 | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | 6 | - |
| Q3 2020 | - | 1 | - |
| Q2 2020 | - | 2 | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | 1 | - | - |
| Q2 2019 | - | - | - |
| Q1 2019 | - | 1 | - |
| Q4 2018 | - | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 7 open market sell trades of Supernus Pharmaceuticals's stocks.
Supernus Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| RDY | Dr. Reddy's Laboratories Limited |
| ANIP | ANI Pharmaceuticals, Inc. |
| PAHC | Phibro Animal Health Corporation |
| RGC | Regencell Bioscience Holdings Limited |
| SSIC | Silver Spike Investment Corp. |
| DCPH | Deciphera Pharmaceuticals, Inc. |
| PBH | Prestige Consumer Healthcare Inc. |
| PCRX | Pacira BioSciences, Inc. |
| COLL | Collegium Pharmaceutical, Inc. |
| EVO | Evotec SE |
| EGRX | Eagle Pharmaceuticals, Inc. |
SUPN Ownership FAQ
Who Owns Supernus Pharmaceuticals?
Supernus Pharmaceuticals is owned by institutional shareholders (106.11%), insiders (5.01%), and public (-11.12%). The largest institutional shareholder of Supernus Pharmaceuticals is BLACKROCK INC. (18.90% of total shares) and the top mutual fund owner is SCHRODER GLOBAL SERIES TRUST (2.67% of total shares).
Who are the major institutional shareholders of Supernus Pharmaceuticals?
Supernus Pharmaceuticals's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, DIMENSIONAL FUND ADVISORS LP, and MACQUARIE GROUP LTD. The top five shareholders own together 49.74% of the company's share outstanding.
How many Supernus Pharmaceuticals shareholders are there?
As of Jun 2024, there are 242 institutional shareholders of Supernus Pharmaceuticals.
What percentage of Supernus Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC owns 10.39M shares of Supernus Pharmaceuticals, representing 18.90% of the company's total shares outstanding, valued at $278M (as of Jun 2024).
What percentage of Supernus Pharmaceuticals is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 6.14M shares of Supernus Pharmaceuticals (SUPN), compromising 11.16% of the company, valued at $164.18M.
What percentage of Supernus Pharmaceuticals is owned by ARMISTICE CAPITAL, LLC?
ARMISTICE CAPITAL, LLC is the third largest holder of Supernus Pharmaceuticals. The company owns 5.27M of the company's shares outstanding (worth $141.03M).